Case Study: Market Access for Mechanical Thrombectomy in England

Diverse healthcare structures and reimbursement pathways in Europe present unique challenges for medical device companies. Varying reimbursement frameworks, technology assessment processes, and funding mechanisms can complicate the rollout of new treatments. This White Paper provides a detailed case study on how developers of medical technology can successfully navigate reimbursement pathways in key European markets, focusing on England.

Key insights include:

• Reimbursement milestones: Step-by-step analysis of mechanical thrombectomy’s market access journey in England
• Coding strategies and tariff structures: Effective approaches for securing accurate reimbursement codes and optimizing tariffs
• Payer engagement and NICE assessments: Best practices for gaining approval and overcoming commissioning hurdles

Navigating the English reimbursement landscape requires a deep understanding of payer dynamics, coding practices, and the evolving role of commissioning bodies. Failure to address these factors can lead to delays, revenue loss, and limited patient access. This White Paper provides actionable strategies and proven solutions to help MedTech companies secure timely market access and reimbursement for high-impact technologies.
Gain a competitive edge and optimize your market access strategy with practical insights from industry experts.